18
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Apparent Life-Threatening Events (ALTE): Italian guidelines

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Five years after the first edition, we have revised and updated the guidelines, re-examining the queries and relative recommendations, expanding the issues addressed with the introduction of a new entity, recently proposed by the American Academy of Pediatrics: BRUE, an acronym for Brief Resolved Unexplained Events. In this manuscript we will use the term BRUE only to refer to mild, idiopathic cases rather than simply replace the acronym ALTE per se.

          In our guidelines the acronym ALTE is used for severe cases that are unexplainable after the first and second level examinations.

          Although the term ALTE can be used to describe the common symptoms at the onset, whenever the aetiology is ascertained, the final diagnosis may be better specified as seizures, gastroesophageal reflux, infection, arrhythmia, etc. Lastly, we have addressed the emerging problem of the so-called Sudden Unexpected Postnatal Collapse (SUPC), that might be considered as a severe ALTE occurring in the first week of life.

          Related collections

          Most cited references134

          • Record: found
          • Abstract: found
          • Article: not found

          The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America

          Abstract Evidenced-based guidelines for management of infants and children with community-acquired pneumonia (CAP) were prepared by an expert panel comprising clinicians and investigators representing community pediatrics, public health, and the pediatric specialties of critical care, emergency medicine, hospital medicine, infectious diseases, pulmonology, and surgery. These guidelines are intended for use by primary care and subspecialty providers responsible for the management of otherwise healthy infants and children with CAP in both outpatient and inpatient settings. Site-of-care management, diagnosis, antimicrobial and adjunctive surgical therapy, and prevention are discussed. Areas that warrant future investigations are also highlighted.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Pediatric Gastroesophageal Reflux Clinical Practice Guidelines: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN)

            To develop a North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) international consensus on the diagnosis and management of gastroesophageal reflux and gastroesophageal reflux disease in the pediatric population. An international panel of 9 pediatric gastroenterologists and 2 epidemiologists were selected by both societies, which developed these guidelines based on the Delphi principle. Statements were based on systematic literature searches using the best-available evidence from PubMed, Cumulative Index to Nursing and Allied Health Literature, and bibliographies. The committee convened in face-to-face meetings 3 times. Consensus was achieved for all recommendations through nominal group technique, a structured, quantitative method. Articles were evaluated using the Oxford Centre for Evidence-based Medicine Levels of Evidence. Using the Oxford Grades of Recommendation, the quality of evidence of each of the recommendations made by the committee was determined and is summarized in appendices. More than 600 articles were reviewed for this work. The document provides evidence-based guidelines for the diagnosis and management of gastroesophageal reflux and gastroesophageal reflux disease in the pediatric population. This document is intended to be used in daily practice for the development of future clinical practice guidelines and as a basis for clinical trials.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              An official ATS clinical policy statement: Congenital central hypoventilation syndrome: genetic basis, diagnosis, and management.

              Congenital central hypoventilation syndrome (CCHS) is characterized by alveolar hypoventilation and autonomic dysregulation. (1) To demonstrate the importance of PHOX2B testing in diagnosing and treating patients with CCHS, (2) to summarize recent advances in understanding how mutations in the PHOX2B gene lead to the CCHS phenotype, and (3) to provide an update on recommendations for diagnosis and treatment of patients with CCHS. Committee members were invited on the basis of their expertise in CCHS and asked to review the current state of the science by independently completing literature searches. Consensus on recommendations was reached by agreement among members of the Committee. A review of pertinent literature allowed for the development of a document that summarizes recent advances in understanding CCHS and expert interpretation of the evidence for management of affected patients. A PHOX2B mutation is required to confirm the diagnosis of CCHS. Knowledge of the specific PHOX2B mutation aids in anticipating the CCHS phenotype severity. Parents of patients with CCHS should be tested for PHOX2B mutations. Maintaining a high index of suspicion in cases of unexplained alveolar hypoventilation will likely identify a higher incidence of milder cases of CCHS. Recommended management options aimed toward maximizing safety and optimizing neurocognitive outcome include: (1) biannual then annual in-hospital comprehensive evaluation with (i) physiologic studies during awake and asleep states to assess ventilatory needs during varying levels of activity and concentration, in all stages of sleep, with spontaneous breathing, and with artificial ventilation, and to assess ventilatory responsiveness to physiologic challenges while awake and asleep, (ii) 72-hour Holter monitoring, (iii) echocardiogram, (iv) evaluation of ANS dysregulation across all organ systems affected by the ANS, and (v) formal neurocognitive assessment; (2) barium enema or manometry and/or full thickness rectal biopsy for patients with a history of constipation; and (3) imaging for neural crest tumors in individuals at greatest risk based on PHOX2B mutation.
                Bookmark

                Author and article information

                Contributors
                raffaele.piumelli@meyer.it
                Journal
                Ital J Pediatr
                Ital J Pediatr
                Italian Journal of Pediatrics
                BioMed Central (London )
                1824-7288
                12 December 2017
                12 December 2017
                2017
                : 43
                : 111
                Affiliations
                [1 ]ISNI 0000 0004 1757 8562, GRID grid.413181.e, Sleep Breathing Disorders and SIDS Center, Meyer Children’s Hospital, ; Firenze, Italy
                [2 ]ISNI 0000 0004 1760 7415, GRID grid.418712.9, Department of Perinatal Medicine, , Institute for Maternal and Child Health-IRCCS Burlo Garofolo, ; Trieste, Italy
                [3 ]ISNI 0000000121724807, GRID grid.18147.3b, Paediatric Department, , University of Insubria, ; Varese, Italy
                [4 ]ISNI 0000 0004 1757 2304, GRID grid.8404.8, Department of Neuroscience, Psychology, Drug Research and Child Health, , University of Florence, ; Firenze, Italy
                [5 ]Neonatal Intensive Care Unit, Del Ponte Hospital, Varese, Italy
                [6 ]ISNI 0000 0004 1760 0109, GRID grid.419504.d, SIDS Center, Pediatric Emergency Department, “G. Gaslini” Children’s Hospital, ; Genova, Italy
                [7 ]ISNI 0000 0001 0727 6809, GRID grid.414125.7, Pneumology Unit - University Hospital Pediatric Department, , Bambino Gesù Children Hospital, IRCCS, ; Rome, Italy
                [8 ]SIDS/ALTE Center, Buccheri la Ferla Hospital, Palermo, Italy
                [9 ]Pediatric Cardiology, Santo Bambino Hospital, Catania, Italy
                [10 ]ISNI 0000 0004 1760 0109, GRID grid.419504.d, Cardiology Unit, G. Gaslini Children’s Hospital, ; Genova, Italy
                [11 ]ISNI 0000 0004 1757 8562, GRID grid.413181.e, Clinical Trial Office, Meyer Children’s Hospital, ; Firenze, Italy
                [12 ]ISNI 0000 0004 1760 0109, GRID grid.419504.d, Emergency Department of Paediatrics, G. Gaslini Children’s Hospital, ; Genova, Italy
                [13 ]National Neurological Institute IRCCS C, Mondino, Pavia, Italy
                [14 ]Pediatric Unit, Giovanni XXIII Hospital, Bari, Italy
                Author information
                http://orcid.org/0000-0002-1609-6241
                Article
                429
                10.1186/s13052-017-0429-x
                5728046
                29233182
                4ed78047-b63e-44fa-b8ed-db6973aac9e9
                © The Author(s). 2017

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 19 May 2017
                : 22 August 2017
                Categories
                Review
                Custom metadata
                © The Author(s) 2017

                Pediatrics
                apparent life-threatening events,brief resolved unexplained events,sudden unexpected early neonatal death,sudden unexpected postnatal collapse

                Comments

                Comment on this article